NCT04290806Recruiting
Registry Platform Gastric/Esophageal Cancer (SAPHIR)
Clinical Research Platform For Molecular Testing, Treatment, Quality Of Life And Outcome Of Patients With Esophageal, Gastric Or Gastroesophageal Junction Cancer Requiring Palliative Systemic Therapy
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1900 (estimated)
- First submitted
- 27 Feb 2020
- Start date
- 4 Dec 2019
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- iOMEDICO AG
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT04290806
What you commit to
- Study type: Observational
- Planned participants: 1900
- From 4 Dec 2019 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No systemic therapy for ESCC, EAC, GAC or GEJAC
Who the study is looking for
- Histologically proven stage IV (metastatic) ESCC, EAC, GAC or GEJAC
- Planned palliative systemic first-line therapy
- Age \>= 18 years
- Signed informed consent (IC)
- Patients answering questionnaires: IC before first therapy cycle
- Patients not answering questionnaires: IC latest 4 weeks after start of first therapy cycle
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multiple sites, Gemany Coordinator of this site? Confirm its status | Multiple Locations | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.